FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090394 [Registered on: 07/07/2025] Trial Registered Prospectively
Last Modified On: 04/07/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Other 
Public Title of Study   Homoeopathy for sleep problems 
Scientific Title of Study   Individualized Homoeopathic treatment in Chronic Primary Insomnia – A Pilot study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vaishali Shinde 
Designation  Research Officer S 3 
Affiliation  Regional Research Institute for Homoeopathy, Kharghar, Navi Mumbai 
Address  Room no. 5,Ground Floor,Regional Research Institute for Homoeopathy, RRIU RRIH, Plot,38 39, Sector 18 Rd, Sector 18, Kharghar, Navi Mumbai, Maharashtra 410210

Mumbai
MAHARASHTRA
410210
India 
Phone  9920425854  
Fax    
Email  drvhsb@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Divya Taneja 
Designation  Research Officer Homoeopathy 
Affiliation  Central Council for Research in Homoeopathy,New Delhi 
Address  Room no.309,Central Council for Research in Homoeopathy ,D Block,Janakpuri,New Delhi West Delhi 110058 India

New Delhi
DELHI
110058
India 
Phone  9810305068  
Fax    
Email  drdivyataneja@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Renu Mittal 
Designation  Research Officer S 4 
Affiliation  Central Council for Research in Homoeopathy,New Delhi 
Address  Room no.304,Central Council for Research in Homoeopathy, 61 65, Institutional Area, opp. D Block, Janakpuri,New Delhi 110058

New Delhi
DELHI
110058
India 
Phone  9717511115  
Fax    
Email  renumittal8@gmail.com  
 
Source of Monetary or Material Support  
NIL  
 
Primary Sponsor  
Name  Central Council for Research in Homoeopathy, New Delhi 
Address  Central Council for Research in Homoeopathy,61 65, Institutional Area, opp. D Block, Janakpuri, New Delhi 110058 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 3  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nidhi Mahajan  Central Research Institute of Homoeopathy, Jaipur  OPD No.3, Ground Floor, Department Homoeopathy, Division Clinical Research,RR4R MQ7, Sector 26, Pratap Nagar, Jaipur, Rajasthan 302033
Jaipur
RAJASTHAN 
9119124757

drnidhimahajan1@gmail.com 
Dr Ramesh Bawaskar  Regional Research Institute for Homoeopathy, Navi Mumbai  Room no.01 Department- Homoeopathy, Division Clinical research Regional Research Institute for Homoeopathy, Mumbai, Plot No- 38 & 39, Sector- 18, Kharghar, Navi Mumbai-410210. Maharashtra.
Mumbai
MAHARASHTRA 
9769888743

drbrsb@gmail.com 
Dr Vaishali Shinde  Regional Research Institute for Homoeopathy, Navi Mumbai  Room no.5,Ground Floor, Department Homoeopathy, Division Clinical Research, RRIH, Plot, 38 39, Sector 18 Rd, Sector 18, Kharghar, Navi Mumbai, Maharashtra 410210
Mumbai
MAHARASHTRA 
9920425854

drvhsb@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
CENTRAL ETHICS COMMITTEE  Approved 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
REGIONAL INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G470||Insomnia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic Medicines  Individualized Homoeopathic Medicines in centesimal potency will be prescribed as per the principles of Homoeopathy. No new medicines will be used. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Participants of both sexes of age greater than 18 years visiting OPD of RRI Navi Mumbai and CRI Jaipur.
Willing to give consent for participation.
Participants presenting with complaints of sleep disorders hard to fall asleep stay sleep or wake up too early and not able to sleep back for at least 3 nights a week for last 3 months.
Participants whos sleep score with Insomnia Severity Index is ranging between 8 to 28 
 
ExclusionCriteria 
Details  Anyone who has any systemic illness such as Uncontrolled Diabetes, Hypertension, Seizures, Uncontrolled infections or any other vital organ failure.
Substance abuse and/or substance dependence.
Persons suffering from known psychiatric disease who are taking anti-psychotropic drugs.
Persons suffering from diseases causing sleep disturbances like BEP, Asthma, COPD, etc
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To Change Insomnia Severity Scale (ISI)score.  At Baseline , every 15 days follow up , at every month follow up.
 
 
Secondary Outcome  
Outcome  TimePoints 
To Improve the quality of Sleep with decreasing Pittsburgh Sleep Quality Index (PSQI) score  At baseline , at every month follow up 
Outcome in Relation to Impact on Daily Living (ORIDL Scale)  At every 15 days follow up , at every month follow up.
 
Medicines that would be found useful in the three patterns of insomnia (as identified in the survey study).  At Baseline , every 15 days follow up , at every month follow up.
 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/07/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This prospective single arm pilot study is designed to evaluate the effectiveness of individualized homoeopathic intervention in patients suffering from chronic primary insomnia. The study will be conducted at the Regional Research Institute for Homoeopathy Navi Mumbai and the Central Research Institute of Homoeopathy Jaipur over a 12 month period. A total of 30 participants aged above 18 years meeting inclusion criteria based on Insomnia Severity Index scoring between 8 to 28 and chronic insomnia symptoms will be enrolled. Each participant will receive individualized homoeopathic medicines in centesimal potencies for four months with fortnightly follow ups. The primary outcome will be assessed using the Insomnia Severity Index ISI and secondary outcomes will include the Pittsburgh Sleep Quality Index PSQI and the Outcome in Relation to Impact on Daily Living ORIDL scale assessed at Baseline, every 15 day follow up  and every monthly follow up. 
Close